Abstract

Background: Early hematoma expansion (HE) occurs in patients with intracerebral hemorrhage (ICH) within the first few hours from ICH onset. Hematoma expansion has been considered as an independent predictor of poor clinical outcome and mortality after ICH. Island sign (IS) on the non-contrast computed tomography (NCCT) appears to increase the rate of detection of HE. However, there is insufficient evidence to declare that IS is an independent predictor for ICH patients prognosis and classification.Objectives: To investigate whether IS on NCCT could predict HE and functional outcome following ICH.Methods: Major databases were systematically searched, including PubMed, EMBASE, Cochrane library, and the Chinese database (CNKI, VIP, and Wanfang databases). Studies about the associations between IS and HE or IS and clinical outcome were included. The pooled result used the odds ratio (OR) with a 95% confidence interval (CI) as effect size. Heterogeneity and publication bias were assessed. Subgroup analysis and meta-regression were applied to detect potential factors of heterogeneity.Results: Eleven studies with 4,310 patients were included in the final analysis. The average incidence rate of IS and HE were 21.58 and 33%, respectively. The ideal timing for assessing HE was also not uniform or standardized. We separately performed two meta-analyses. First, 10 studies were included to estimate the association between IS and HE. The pooled OR was statistically significant (OR = 7.61, 95% CI = 3.10–18.67, P < 0.001). Second, four studies were included in the meta-analysis, and the pooled result showed that IS had a significantly positive relationship with poor outcome (OR = 3.83, 95% CI = 2.51–5.85, P < 0.001).Conclusions: This meta-analysis showed that NCCT IS is of great importance and value for evaluation of HE and poor outcome in patients with ICH. Future studies should focus on developing consensus guidelines, and more studies with large sample size and longitudinal design are needed to validate the conclusions.

Highlights

  • Intracerebral hemorrhage (ICH), the most devastating subtype of stroke, leads to high mortality and morbidity [1, 2]

  • The preliminary search identified 278 records: PubMed (n = 136), EMBASE (n = 74), Cochrane Library (n = 7), CNKI (n = 8), VIP (n = 4), Wangfang (n = 6), and additional 43 records identified through Web of Science and Google Scholar

  • 11 studies were included in the metaanalysis

Read more

Summary

Introduction

Intracerebral hemorrhage (ICH), the most devastating subtype of stroke, leads to high mortality and morbidity [1, 2]. Hematoma expansion (HE) is used referring to significant hemorrhage enlargement (>33% and/or >6 mL) and occurs within the first few hours of onset in 38% of ICH patients [3]. The spot sign on computed tomography angiography (CTA) is recognized as an independent imaging marker with reliable sensitivity and specificity to identify HE [5]. Non-contrast computed tomography (NCCT) is a widely available and generally well-tolerated alternative to CTA. Hematoma expansion (HE) occurs in patients with intracerebral hemorrhage (ICH) within the first few hours from ICH onset. Hematoma expansion has been considered as an independent predictor of poor clinical outcome and mortality after ICH. There is insufficient evidence to declare that IS is an independent predictor for ICH patients prognosis and classification

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call